ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 610459 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 610459; 2) Community: the network communities that were significantly associated with the response to NSC 610459; 3) Molecule: the relationships between components within communities and NSC 610459; 4) MDR: the compounds that were significantly associated with the NSC 610459.

NSC Compound Enrichment Correlation
NSC 728091 6-[(3-Hydroxy)-1-propyl]-5,6-dihydro-2,3-dimethoxy-8,9-methy lenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.0100995289754788 0.59746765
NSC 735037 Camptothecin Derivative 0.0100995289754788 0.84580889
NSC 745929 Null 0.0100995289754788 -0.033568461
NSC 755465 Null 0.0100995289754788 0.025122959
NSC 226080 Sirolimus 0.0103070729572494 0.17955004
NSC 307241 Adriamycin deriv., mixt. with hydroxyethyl starch (cross-linked) 0.0103070729572494 0.60362682
NSC 3080 s-Triazine, 4,6-diamino-1-(m-chlorophenyl)-1,2-dihydro-2,2-dimethyl-, monohydrochloride (8CI) 0.0103070729572494 0.43763897
NSC 613662 Null 0.0103070729572494 0.2807644
NSC 663790 Null 0.0103070729572494 0.59162135
NSC 682561 Cardenolide 2 0.0103070729572494 0.38275332
Total:64  Current:16    [First] [Prev] [Next] [Last]